Since the past decades, more lung cancer patients have been experiencing lasting benefits
from immunotherapy. It is imperative to accurately and intelligently select appropriate …

With the recent success in the application of immunotherapy for treating various advanced
cancers, the tumor microenvironment has rapidly become an important field of research. The …

Background Programmed death-ligand 1 (PD-L1) assessment of lung cancer in
immunohistochemical assays was only approved diagnostic biomarker for immunotherapy …

Advancements in the development of computer-aided decision (CAD) systems for clinical
routines provide unquestionable benefits in connecting human medical expertise with …

Background This study set out to develop a computed tomography (CT)-based wavelet
transforming radiomics approach for grading pulmonary lesions caused by COVID-19 and to …

Objectives Our study aimed to develop and validate an efficient ultrasound image‐based
radiomic model for determining the Achilles tendinopathy in skiers. Methods A total of 88 feet …

Simple Summary Lung cancer therapeutics have dramatically improved in recent years.
Indeed, precision oncology could be exemplified by non-small cell lung cancer (NSCLC) …

Objectives To develop and validate magnetic resonance imaging (MRI)-based pre-
Radiomics and delta-Radiomics models for predicting the treatment response of local …

The search for understanding immunotherapy response has sparked interest in diverse
areas of oncology, with artificial intelligence (AI) and radiomics emerging as promising tools …

Rationale and objectives Programmed Death-Ligand 1 (PD-L1) is an important biomarker
for patient selection of immunotherapy in gastric cancer (GC). This study aimed to construct …